Injury mechanisms in acute intracerebral hemorrhage

D Andrew Wilkinson1, Aditya S Pandey1, B Gregory Thompson1

  • 1Department of Neurosurgery, University of Michigan, Ann Arbor, MI, USA.

Neuropharmacology
|September 27, 2017
PubMed

Insights

Intracerebral hemorrhage (ICH) remains a leading cause of death, with high mortality despite ongoing research. Current trials focus on minimally invasive clot removal and new drugs to improve recovery from brain bleeds.

Area of Science:

  • Neurology
  • Neurosurgery
  • Stroke Medicine

Background:

  • Intracerebral hemorrhage (ICH) is the most frequent type of hemorrhagic stroke.
  • ICH incidence is rising due to an aging global population.
  • Despite extensive research, ICH mortality rates remain high, with no proven interventional therapies.

Purpose of the Study:

  • To review current knowledge on ICH injury mechanisms.
  • To discuss recent clinical trial outcomes for ICH.
  • To explore novel signaling pathways for hematoma clearance.

Main Methods:

  • Literature review of ICH mechanisms and injury.
  • Analysis of recent clinical trial data for ICH therapies.
  • Examination of emerging signaling pathways in hematoma resolution.

Main Results:

  • No interventional therapy has yet improved ICH outcomes.
  • Ongoing clinical trials are evaluating minimally invasive clot removal.
  • Pharmacologic strategies for post-ICH recovery are under investigation.

Conclusions:

  • Minimally invasive clot removal shows promise for ICH treatment.
  • Pharmacologic interventions may enhance recovery after ICH.
  • Further research into signaling pathways is crucial for developing effective therapies.